116.68
0.02%
0.13
前日終値:
$116.81
開ける:
$117.099
24時間の取引高:
1.02M
Relative Volume:
0.23
時価総額:
$206.00B
収益:
$41.22B
当期純損益:
$5.77B
株価収益率:
39.69
EPS:
2.94
ネットキャッシュフロー:
$6.49B
1週間 パフォーマンス:
-0.95%
1か月 パフォーマンス:
-1.49%
6か月 パフォーマンス:
+13.58%
1年 パフォーマンス:
+11.40%
Abbott Laboratories Stock (ABT) Company Profile
名前
Abbott Laboratories
セクター
電話
(224) 667-6100
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
ABT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
116.70 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
387.37 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
90.11 | 134.13B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
85.75 | 110.81B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
69.68 | 41.60B | 6.60B | 4.16B | 490.10M | 6.93 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-10-08 | 開始されました | Oppenheimer | Outperform |
2024-09-19 | 開始されました | Piper Sandler | Overweight |
2024-07-30 | ダウングレード | Edward Jones | Buy → Hold |
2024-05-30 | 開始されました | Goldman | Buy |
2023-07-21 | アップグレード | Wolfe Research | Underperform → Peer Perform |
2023-05-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2023-04-20 | 繰り返されました | Barclays | Overweight |
2023-04-20 | 繰り返されました | Bernstein | Outperform |
2023-04-20 | 繰り返されました | JP Morgan | Overweight |
2023-04-20 | 繰り返されました | Raymond James | Outperform |
2023-04-20 | 繰り返されました | UBS | Buy |
2023-04-20 | 繰り返されました | Wolfe Research | Underperform |
2023-03-29 | 開始されました | UBS | Buy |
2022-10-26 | 開始されました | Mizuho | Neutral |
2022-10-18 | 開始されました | Barclays | Overweight |
2022-10-12 | 開始されました | Jefferies | Hold |
2022-07-06 | 開始されました | Wolfe Research | Underperform |
2022-03-02 | 再開されました | BofA Securities | Buy |
2022-01-27 | 繰り返されました | Credit Suisse | Outperform |
2022-01-27 | 繰り返されました | Morgan Stanley | Overweight |
2022-01-27 | 繰り返されました | Raymond James | Outperform |
2022-01-27 | 繰り返されました | UBS | Buy |
2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
2021-10-27 | アップグレード | Atlantic Equities | Neutral → Overweight |
2021-10-14 | 開始されました | Redburn | Neutral |
2021-05-25 | 開始されました | Barclays | Overweight |
2021-04-15 | 開始されました | Atlantic Equities | Neutral |
2021-01-28 | アップグレード | BTIG Research | Neutral → Buy |
2020-09-11 | 開始されました | Wolfe Research | Outperform |
2020-06-01 | ダウングレード | Goldman | Neutral → Sell |
2020-03-05 | 開始されました | Citigroup | Buy |
2020-02-13 | 開始されました | Goldman | Neutral |
2020-02-06 | 再開されました | BTIG Research | Neutral |
2020-01-02 | ダウングレード | Guggenheim | Buy → Neutral |
2019-06-13 | 繰り返されました | BofA/Merrill | Buy |
2019-02-07 | 繰り返されました | BofA/Merrill | Buy |
2019-01-02 | ダウングレード | Citigroup | Neutral → Sell |
2018-11-30 | アップグレード | Goldman | Neutral → Buy |
2018-10-16 | 開始されました | Barclays | Overweight |
2018-06-27 | 開始されました | Bernstein | Outperform |
2018-01-30 | 繰り返されました | Citigroup | Neutral |
2018-01-25 | 繰り返されました | Stifel | Buy |
2018-01-25 | アップグレード | William Blair | Mkt Perform → Outperform |
2018-01-03 | 開始されました | Evercore ISI | Outperform |
2018-01-02 | アップグレード | JP Morgan | Neutral → Overweight |
2018-01-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2017-10-19 | 繰り返されました | RBC Capital Mkts | Outperform |
2017-10-19 | 繰り返されました | Stifel | Buy |
すべてを表示
Abbott Laboratories (ABT) 最新ニュース
Abbott Laboratories stock underperforms Monday when compared to competitors - MarketWatch
3 Reasons to Buy DexCom Stock Like There's No Tomorrow - The Motley Fool
Endoprosthesis Market Size to Surpass USD 60.39 Billion by 2032 at a CAGR of 9.86% - GlobeNewswire Inc.
Benjamin Edwards Inc. Raises Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Atom Investors LP Cuts Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Aureus Asset Management LLC Has $30.73 Million Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Cardiac Implants Market Overall Study Report 2024-2031 | Abbott - openPR
Calculating The Fair Value Of Abbott Laboratories (NYSE:ABT) - Simply Wall St
7,527 Shares in Abbott Laboratories (NYSE:ABT) Bought by B&L Asset Management LLC - MarketBeat
Abbott Laboratories (NYSE:ABT) is Bellevue Group AG's 9th Largest Position - MarketBeat
Fred Alger Management LLC Acquires Shares of 43,301 Abbott Laboratories (NYSE:ABT) - MarketBeat
PDT Partners LLC Sells 8,500 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Caisse DE Depot ET Placement DU Quebec Increases Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Short Interest in Abbott Laboratories (NYSE:ABT) Declines By 14.4% - MarketBeat
Abbott Laboratories (XKAZ:ABT_KZ) Price-to-Operating-Cash-F - GuruFocus.com
Captrust Financial Advisors Sells 69,739 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Rockefeller Capital Management L.P. Decreases Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Quantbot Technologies LP Sells 141,543 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch
Atlantic Union Bankshares Corp Sells 4,950 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Martingale Asset Management L P Sells 52,620 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Hantz Financial Services Inc. Has $33.26 Million Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Northwest & Ethical Investments L.P. Acquires 12,842 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
The Zacks Analyst Blog Abbott, BlackRock, ConocoPhillips, NetSol and Optex Systems - Yahoo Finance
Abbott Laboratories (NYSE:ABT) Stock Holdings Lessened by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Public Sector Pension Investment Board Reduces Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Acquires 8,227 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
BBR Partners LLC Boosts Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
CreativeOne Wealth LLC Has $2.48 Million Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Purchases 57,049 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Fmr LLC Lowers Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Protein Therapeutics Market May See a Big Move | Abbott Laboratories, Baxter, F. Hoffmann-La Roche - openPR
Loomis Sayles & Co. L P Acquires 32,021 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Top Research Reports for Abbott, BlackRock & ConocoPhillips - Yahoo Finance
Infant Nutrition Market Detailed Industry Analysis and Key - openPR
BNP Paribas Decreases Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Glenmede Trust Co. NA Has $172.94 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Labs Stock Falls After Baby-Formula Ruling. Reckitt Benckiser Tumbles Too. - MSN
Abbott Laboratories (NYSE:ABT) Shares Sold by Bridgewater Associates LP - MarketBeat
Transamerica Financial Advisors Inc. Makes New Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
Unlocking Intrinsic Value: Analysis of Abbott Laboratories - GuruFocus.com
NEC Baby Formula Lawsuit - Lawsuit Information Center Blog
Judge denies Abbott request for retrial, lower damages in $500M baby formula case - Seeking Alpha
Abbott Laboratories (NYSE:ABT) Shares Bought by Prospector Partners LLC - MarketBeat
D.A. Davidson & CO. Has $17.70 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Dai ichi Life Insurance Company Ltd Sells 10,563 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (XSGO:ABT) GF Value Rank : 6 (As of Nov. 26, 2024) - GuruFocus.com
The Manufacturers Life Insurance Company Decreases Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Abbott Laboratories (ABT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):